Skip over global navigation links
U.S. Department of Health and Human Services

ASPR Blog Series: Combatting Antibiotic Resistance

“BARDA has developed a series of blogs on “Combatting Antibiotic Resistance” which will explore the threat of antibiotic resistance and discuss current and future initiatives that the Office of the Assistant Secretary for Preparedness and Response (ASPR) is undertaking to address the increasingly prevalent public health threat of antibiotic resistance.  Through this series we will enhance public understanding of the antibiotic resistance crisis, our current and future strategies to mitigate the threat and explore ways you can help. Together we can build a resilient community”
Robin Robinson, PhD
Director, Biomedical Advanced Research and Development Authority (BARDA)
ASPR Assistant Deputy Secretary
The “Combatting Antibiotic Resistance” blog series is designed to highlight the antibiotic resistance crisis and some of the actions that are being taken to mitigate the threat.   To stay up to date as new blog posts are published, subscribe to the ASPR Blog RSS feed, follow @PHEgov on Twitter or Like us on Facebook.
Learn about antibiotic resistance and find out why it is a public health concern.  We will discuss why ASPR is involved in combating this threat to ensure we have resilient communities.  Learn More >>

Part 2: Why is BARDA positioned to respond to the threat of antibiotic resistance?
Certain business challenges have slowed the development of new medical countermeasures.  Learn how BARDA has successfully responded to these challenges and how we are leveraging our experiences to address the threat of antibiotic resistance.  Learn More >>

Part 3: BARDA’s Broad Spectrum Antimicrobials (BSA) program
BARDA’s Broad Spectrum Antimicrobials (BSA) program is leading ASPR’s effort to develop new antibiotics to address the threat of antibiotic resistance. Learn More >>

Part 4: Using Innovative Business Models to Enhance Antibiotic Development

BARDA is working with its partners to revitalize the antibiotic pipeline by providing incentives for pharmaceutical and biotechnology companies to engage or reengage in antibiotic development. Learn More >>

Part 5: You Can Help Combat the Threat of Antibiotic Resistance
Interested in helping find and implement solutions to this threat?   Learn how individuals, organizations and industry can come together to address the threat of antibiotic resistance. Learn More >>

  • This page last reviewed: September 18, 2014